nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—CYP1A2—Fluorouracil—colon cancer	0.153	0.494	CbGbCtD
Griseofulvin—CYP3A4—Irinotecan—colon cancer	0.0836	0.27	CbGbCtD
Griseofulvin—CYP3A4—Vincristine—colon cancer	0.073	0.236	CbGbCtD
Griseofulvin—Hyperbilirubinaemia—Irinotecan—colon cancer	0.0226	0.0327	CcSEcCtD
Griseofulvin—Oral candidiasis—Capecitabine—colon cancer	0.0216	0.0313	CcSEcCtD
Griseofulvin—Neuropathy—Vincristine—colon cancer	0.0198	0.0286	CcSEcCtD
Griseofulvin—Coagulopathy—Capecitabine—colon cancer	0.0176	0.0255	CcSEcCtD
Griseofulvin—Proteinuria—Capecitabine—colon cancer	0.0156	0.0226	CcSEcCtD
Griseofulvin—Protein urine present—Capecitabine—colon cancer	0.0154	0.0223	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Capecitabine—colon cancer	0.0151	0.0219	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.0149	0.0216	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.0143	0.0207	CcSEcCtD
Griseofulvin—Candida infection—Capecitabine—colon cancer	0.0131	0.019	CcSEcCtD
Griseofulvin—Neuropathy—Capecitabine—colon cancer	0.0129	0.0187	CcSEcCtD
Griseofulvin—Proteinuria—Methotrexate—colon cancer	0.0116	0.0168	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vincristine—colon cancer	0.0116	0.0167	CcSEcCtD
Griseofulvin—Protein urine present—Methotrexate—colon cancer	0.0115	0.0166	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Methotrexate—colon cancer	0.0112	0.0163	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Methotrexate—colon cancer	0.0108	0.0157	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Fluorouracil—colon cancer	0.0108	0.0156	CcSEcCtD
Griseofulvin—Agranulocytosis—Fluorouracil—colon cancer	0.0103	0.0149	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00997	0.0144	CcSEcCtD
Griseofulvin—Erythema—Fluorouracil—colon cancer	0.00859	0.0124	CcSEcCtD
Griseofulvin—Leukopenia—Vincristine—colon cancer	0.00824	0.0119	CcSEcCtD
Griseofulvin—Leukopenia—Irinotecan—colon cancer	0.00803	0.0116	CcSEcCtD
Griseofulvin—Leukopenia—Fluorouracil—colon cancer	0.00769	0.0111	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Capecitabine—colon cancer	0.00753	0.0109	CcSEcCtD
Griseofulvin—Confusional state—Irinotecan—colon cancer	0.00738	0.0107	CcSEcCtD
Griseofulvin—Agranulocytosis—Capecitabine—colon cancer	0.00717	0.0104	CcSEcCtD
Griseofulvin—Confusional state—Fluorouracil—colon cancer	0.00707	0.0102	CcSEcCtD
Griseofulvin—Hepatitis—Capecitabine—colon cancer	0.00689	0.00999	CcSEcCtD
Griseofulvin—Insomnia—Vincristine—colon cancer	0.0068	0.00984	CcSEcCtD
Griseofulvin—Paraesthesia—Vincristine—colon cancer	0.00675	0.00977	CcSEcCtD
Griseofulvin—Insomnia—Irinotecan—colon cancer	0.00662	0.00959	CcSEcCtD
Griseofulvin—Paraesthesia—Irinotecan—colon cancer	0.00657	0.00952	CcSEcCtD
Griseofulvin—Erythema multiforme—Capecitabine—colon cancer	0.00652	0.00944	CcSEcCtD
Griseofulvin—Fatigue—Vincristine—colon cancer	0.00648	0.00938	CcSEcCtD
Griseofulvin—Dyspepsia—Irinotecan—colon cancer	0.00644	0.00933	CcSEcCtD
Griseofulvin—Insomnia—Fluorouracil—colon cancer	0.00634	0.00918	CcSEcCtD
Griseofulvin—Fatigue—Irinotecan—colon cancer	0.00631	0.00914	CcSEcCtD
Griseofulvin—Paraesthesia—Fluorouracil—colon cancer	0.00629	0.00912	CcSEcCtD
Griseofulvin—Dyspepsia—Fluorouracil—colon cancer	0.00617	0.00894	CcSEcCtD
Griseofulvin—Feeling abnormal—Irinotecan—colon cancer	0.00603	0.00874	CcSEcCtD
Griseofulvin—Erythema—Capecitabine—colon cancer	0.006	0.00869	CcSEcCtD
Griseofulvin—Feeling abnormal—Fluorouracil—colon cancer	0.00578	0.00837	CcSEcCtD
Griseofulvin—Urticaria—Fluorouracil—colon cancer	0.00557	0.00807	CcSEcCtD
Griseofulvin—Hypersensitivity—Vincristine—colon cancer	0.00554	0.00802	CcSEcCtD
Griseofulvin—Hypersensitivity—Irinotecan—colon cancer	0.00539	0.00781	CcSEcCtD
Griseofulvin—Asthenia—Vincristine—colon cancer	0.00539	0.00781	CcSEcCtD
Griseofulvin—Leukopenia—Capecitabine—colon cancer	0.00537	0.00778	CcSEcCtD
Griseofulvin—Agranulocytosis—Methotrexate—colon cancer	0.00534	0.00773	CcSEcCtD
Griseofulvin—Asthenia—Irinotecan—colon cancer	0.00525	0.00761	CcSEcCtD
Griseofulvin—Hypersensitivity—Fluorouracil—colon cancer	0.00516	0.00748	CcSEcCtD
Griseofulvin—Diarrhoea—Vincristine—colon cancer	0.00514	0.00745	CcSEcCtD
Griseofulvin—Hepatitis—Methotrexate—colon cancer	0.00513	0.00743	CcSEcCtD
Griseofulvin—Diarrhoea—Irinotecan—colon cancer	0.00501	0.00725	CcSEcCtD
Griseofulvin—Dizziness—Vincristine—colon cancer	0.00497	0.0072	CcSEcCtD
Griseofulvin—Confusional state—Capecitabine—colon cancer	0.00494	0.00715	CcSEcCtD
Griseofulvin—Erythema multiforme—Methotrexate—colon cancer	0.00485	0.00703	CcSEcCtD
Griseofulvin—Dizziness—Irinotecan—colon cancer	0.00484	0.00701	CcSEcCtD
Griseofulvin—Diarrhoea—Fluorouracil—colon cancer	0.0048	0.00695	CcSEcCtD
Griseofulvin—Vomiting—Vincristine—colon cancer	0.00478	0.00692	CcSEcCtD
Griseofulvin—Rash—Vincristine—colon cancer	0.00474	0.00686	CcSEcCtD
Griseofulvin—Dermatitis—Vincristine—colon cancer	0.00473	0.00686	CcSEcCtD
Griseofulvin—Headache—Vincristine—colon cancer	0.00471	0.00682	CcSEcCtD
Griseofulvin—Vomiting—Irinotecan—colon cancer	0.00465	0.00674	CcSEcCtD
Griseofulvin—Dizziness—Fluorouracil—colon cancer	0.00464	0.00671	CcSEcCtD
Griseofulvin—Rash—Irinotecan—colon cancer	0.00461	0.00668	CcSEcCtD
Griseofulvin—Dermatitis—Irinotecan—colon cancer	0.00461	0.00668	CcSEcCtD
Griseofulvin—Headache—Irinotecan—colon cancer	0.00458	0.00664	CcSEcCtD
Griseofulvin—Erythema—Methotrexate—colon cancer	0.00447	0.00647	CcSEcCtD
Griseofulvin—Nausea—Vincristine—colon cancer	0.00446	0.00647	CcSEcCtD
Griseofulvin—Vomiting—Fluorouracil—colon cancer	0.00446	0.00646	CcSEcCtD
Griseofulvin—Insomnia—Capecitabine—colon cancer	0.00443	0.00642	CcSEcCtD
Griseofulvin—Rash—Fluorouracil—colon cancer	0.00442	0.0064	CcSEcCtD
Griseofulvin—Dermatitis—Fluorouracil—colon cancer	0.00442	0.0064	CcSEcCtD
Griseofulvin—Paraesthesia—Capecitabine—colon cancer	0.0044	0.00637	CcSEcCtD
Griseofulvin—Headache—Fluorouracil—colon cancer	0.00439	0.00636	CcSEcCtD
Griseofulvin—Nausea—Irinotecan—colon cancer	0.00435	0.0063	CcSEcCtD
Griseofulvin—Dyspepsia—Capecitabine—colon cancer	0.00431	0.00625	CcSEcCtD
Griseofulvin—Fatigue—Capecitabine—colon cancer	0.00422	0.00612	CcSEcCtD
Griseofulvin—Nausea—Fluorouracil—colon cancer	0.00416	0.00603	CcSEcCtD
Griseofulvin—Feeling abnormal—Capecitabine—colon cancer	0.00404	0.00585	CcSEcCtD
Griseofulvin—Leukopenia—Methotrexate—colon cancer	0.004	0.00579	CcSEcCtD
Griseofulvin—Urticaria—Capecitabine—colon cancer	0.00389	0.00564	CcSEcCtD
Griseofulvin—Confusional state—Methotrexate—colon cancer	0.00368	0.00533	CcSEcCtD
Griseofulvin—Hypersensitivity—Capecitabine—colon cancer	0.00361	0.00523	CcSEcCtD
Griseofulvin—Asthenia—Capecitabine—colon cancer	0.00351	0.00509	CcSEcCtD
Griseofulvin—Diarrhoea—Capecitabine—colon cancer	0.00335	0.00485	CcSEcCtD
Griseofulvin—Insomnia—Methotrexate—colon cancer	0.0033	0.00478	CcSEcCtD
Griseofulvin—Paraesthesia—Methotrexate—colon cancer	0.00327	0.00474	CcSEcCtD
Griseofulvin—Dizziness—Capecitabine—colon cancer	0.00324	0.00469	CcSEcCtD
Griseofulvin—Dyspepsia—Methotrexate—colon cancer	0.00321	0.00465	CcSEcCtD
Griseofulvin—Fatigue—Methotrexate—colon cancer	0.00314	0.00455	CcSEcCtD
Griseofulvin—Vomiting—Capecitabine—colon cancer	0.00311	0.00451	CcSEcCtD
Griseofulvin—Rash—Capecitabine—colon cancer	0.00309	0.00447	CcSEcCtD
Griseofulvin—Dermatitis—Capecitabine—colon cancer	0.00309	0.00447	CcSEcCtD
Griseofulvin—Headache—Capecitabine—colon cancer	0.00307	0.00444	CcSEcCtD
Griseofulvin—Feeling abnormal—Methotrexate—colon cancer	0.003	0.00435	CcSEcCtD
Griseofulvin—Nausea—Capecitabine—colon cancer	0.00291	0.00421	CcSEcCtD
Griseofulvin—Urticaria—Methotrexate—colon cancer	0.0029	0.0042	CcSEcCtD
Griseofulvin—Hypersensitivity—Methotrexate—colon cancer	0.00269	0.00389	CcSEcCtD
Griseofulvin—Asthenia—Methotrexate—colon cancer	0.00262	0.00379	CcSEcCtD
Griseofulvin—Diarrhoea—Methotrexate—colon cancer	0.00249	0.00361	CcSEcCtD
Griseofulvin—Dizziness—Methotrexate—colon cancer	0.00241	0.00349	CcSEcCtD
Griseofulvin—Vomiting—Methotrexate—colon cancer	0.00232	0.00336	CcSEcCtD
Griseofulvin—Rash—Methotrexate—colon cancer	0.0023	0.00333	CcSEcCtD
Griseofulvin—Dermatitis—Methotrexate—colon cancer	0.0023	0.00333	CcSEcCtD
Griseofulvin—Headache—Methotrexate—colon cancer	0.00228	0.00331	CcSEcCtD
Griseofulvin—Nausea—Methotrexate—colon cancer	0.00217	0.00314	CcSEcCtD
